RecallDepth
Class II Ongoing

Tacrolimus Capsules, USP, 0.5 mg, 100-count bottle, Rx Only, Mfd. by Dr. Reddy's Laboratories Limited, Bachupally - 500 090, INDIA; NDC 55111-525-01.

This recall is currently active, issued March 1, 2023. It was issued by Dr. Reddy'S Laboratories, Inc..

Company
Dr. Reddy'S Laboratories, Inc.
Recall Initiated
February 8, 2023
Posted
March 1, 2023
Recall Number
D-0330-2023
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
4,320 bottles
Firm Location
Princeton, NJ, United States
Official Source
View on FDA website ↗

Reason for Recall

Presence of Foreign Tablets/Capsules: Presence of one Tacrolimus 1 mg capsule co-mingled in a bottle containing and labeled as Tacrolimus 0.5 mg capsules.

Distribution

Nationwide in the USA

Lot / Code Info

Lot # C2106445; Exp. 03/2024

More recalls by Dr. Reddy'S Laboratories, Inc.

View all recalls by this company →

Other recent Class II Drug recalls